⚠️ Disclaimer

Sermorelin is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.

Sermorelin (Growth Hormone-Releasing Hormone analog (GRF 1-29)) is a GHRH analog, growth hormone secretagogue researched for endogenous GH stimulation, lean mass gain, fat loss, IGF-1 elevation, improved recovery, bone density. Common dosages range from 200-500 mcg daily administered once daily before bedtime. Below are the most frequently asked questions.

Frequently Asked Questions About Sermorelin

What is Sermorelin?

Sermorelin (Growth Hormone-Releasing Hormone analog (GRF 1-29)) is a GHRH analog, growth hormone secretagogue. Synthetic analog of endogenous GHRH (first 29 amino acids) that stimulates natural GH production. It is researched for endogenous GH stimulation, lean mass gain, fat loss, IGF-1 elevation, improved recovery, bone density.

What is the recommended Sermorelin dosage?

Common dosages range from 200-500 mcg daily, administered once daily before bedtime via subcutaneous injection. Cycles typically run 12-24 weeks; adjust after 4-6 weeks based on IGF-1 levels.

What are the side effects of Sermorelin?

Generally well-tolerated. Minor injection site reactions. Transient facial flushing, dizziness, or nausea in early dosing. Minimal systemic effects due to short half-life.

Is Sermorelin legal?

Originally FDA-approved (1997). Manufacturer discontinued (2008). Legal off-label through compounding pharmacies. Prescription required.

What is the half-life of Sermorelin?

The half-life of Sermorelin is 13 minutes (rapid metabolism), which determines the once daily before bedtime dosing schedule.

How do you reconstitute Sermorelin?

Add bacteriostatic water to the lyophilized Sermorelin vial. Let the water run down the side — never spray on the powder. Swirl gently. Use our peptide calculator for exact amounts.

Can you stack Sermorelin with other peptides?

Combines with GHRP-2 or GHRP-6 for synergistic GH elevation via complementary pathways — GHRH + GHRP produces stronger GH pulses than either alone.

Where can you buy Sermorelin?

Sermorelin is available as a research chemical from vetted suppliers with third-party COA testing.

How long does it take Sermorelin to work?

Initial effects may be noticed within 1-2 weeks, with more significant results typically appearing by weeks 4-8 of a 12-24 weeks; adjust after 4-6 weeks based on IGF-1 levels cycle.

What makes Sermorelin unique?

The only GHRH analog that preserves natural pulsatile GH secretion and feedback mechanisms — stimulates your body's own GH production rather than injecting exogenous hormone.

Complete Guide

Sermorelin : Dosing, Effects & How It Compares to CJC-1295

Read the Full Guide →

Related Reading

Calculate Your Sermorelin Dose

Use our free peptide dosing calculator to get exact reconstitution math and syringe units for Sermorelin.

Open Calculator →

Research-Grade Sourcing

If you're going to research Sermorelin, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.

Ascension → Browse Sermorelin

Limitless → Browse Sermorelin

Frequently Asked Questions

What is Sermorelin?

Sermorelin (Growth Hormone-Releasing Hormone analog (GRF 1-29)) is a GHRH analog, growth hormone secretagogue. Synthetic analog of endogenous GHRH (first 29 amino acids) that stimulates natural GH production. It is researched for endogenous GH stimulation, lean mass gain, fat loss, IGF-1 elevation, improved recovery, bone density.

What is the recommended Sermorelin dosage?

Common dosages: 200-500 mcg daily administered once daily before bedtime via subcutaneous injection. Cycle length: 12-24 weeks; adjust after 4-6 weeks based on IGF-1 levels. Half-life: 13 minutes (rapid metabolism). Use our peptide calculator for exact reconstitution math.

What are the side effects of Sermorelin?

Generally well-tolerated. Minor injection site reactions. Transient facial flushing, dizziness, or nausea in early dosing. Minimal systemic effects due to short half-life.

Is Sermorelin safe?

Sermorelin has shown a favorable safety profile in research. Originally FDA-approved (1997). Manufacturer discontinued (2008). Legal off-label through compounding pharmacies. Prescription required. All research should follow appropriate safety protocols.